Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2003, Pages

  Taramarcaz, Philip ^a   Gibson, Peter G ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85122080487     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003570     Document Type: Review

References (47)

1. Armitage JM, Sin Fai Lam K, Wilkinson I, Faux JA, Hopkin JM. Investigation of the tendency to wheeze in pollen sensitive patients. Clinical and Experimental Allergy 1992;22:916-22.
2. Aubier M, Levy J, Clerici C, Neukirch F, Herman D. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. American Review of Respiratory Disease 1992;146:122-6.
3. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. Journal of Allergy and Clinical Immunology 1992;90:250-6.
4. Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R. Once daily intranasal fluticasone propionate (200 ug) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. Journal of Allergy and Clinical Immunology 1996;98:274-82.
5. Henriksen JM, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing and asthma. American Review of Respiratory Disease 1984;130:1014-8.
6. Mygind N, Bisgaard H, Dahl R. Simultaneous treatment of rhinitis and asthma by nasal inhalation of corticosteroid from a spacer. Allergy 1999;54 Suppl 57:132-53.
7. Pedersen B, Dahl R, Lindqvist N, Mygind N. Nasal inhalation of the glucocorticoid budesonide from a spacer for treatment of patients with pollen rhinitis and asthma. Allergy 1990;45:451-6.
8. Pedersen W, Hjuler I, Bisgaard H, Mygind N. Nasal inhalation of budesonide from a spacer in children with perennial rhinitis and asthma. Allergy 1998;53:383-7.
9. Pelucchi A, Chiapparino A, Mastropasqua B, Marazzini L, Hernandez A, Foresi A. Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to metacholine in allergic rhinitis in response to grass pollens. Journal of Allergy and Clinical Immunology 1995;95:515-23.
10. Rak S, Heinrich C, Jacobsen L, Scheynius A, Venge P. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjonctivitis and asthma. Journal of Allergy and Clinical Immunology 2001;108:921-8.
11. Reed CE, Marcoux JP, Welsh PW. Effects of topical nasal treatment on asthma symptoms. Journal of Allergy and Clinical Immunology 1988;81(5):1042-7.
12. Welch PW, Stricker WE, Chu C-P, Naessens JM, Reese ME, Reed CE, et al. Efficacy of Beclomethasone nasal solution, Flunisolide, and Cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987;62:125-34.
13. Thio BJ, Slingerland GLM, Fredriks AM, Nagelkerke AF, Scheeren RA, Neijens HJ, et al. Influence of intranasal steroids during grass pollen season on bronchial responsiveness in children and young adults with asthma and hay fever. Thorax 2000;55:826-32.
14. Thio BJ, Slingerland GLM, Fredriks AM, Nagelkerke AF, Scheeren RA, Neijens HJ, et al. Influence of intranasal steroids during grass pollen season on bronchial responsiveness in children and young adults with asthma and hay fever. Thorax 2000;55:826-32.
15. Thio BJ, Slingerland GLM, Fredriks AM, Nagelkerke AF, Scheeren RA, Neijens HJ, et al. Influence of intranasal steroids during grass pollen season on bronchial responsiveness in children and young adults with asthma and hay fever. Thorax 2000;55:826-32.
16. Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: Effect on lower airways responsiveness. Journal of Allergy and Clinical Immunology 1993;91(1):97-101.
17. Wood RA, Eggleston PA. The effects of intranasal steroids on nasal and pulmonary responses to cat exposure. American Journal of Respiratory and Critical Care Medicine 1995;151:315-20.
18. Bilancia R, Federici F, Ricatti DG, Buonpensiere L, Ferrannini A, Gramiccioni E. Spirometric value modifications caused by beclamethasone dipropionate nasal spray in patients with persistent allergic rhinitis [Modificazione dei valori spirometrici indotti dal beclomethasone dipropionato per via nasale in pazienti con rhinite allergica perenne]. Archivo Monaldi 1992;47(6):47-53.
19. Gale AE, Harding P, Solomon E. Flunisolide intranasal solution combined with intrabronchial steroids in adults with both bronchial asthma and perennial rhinitis. Annals of Allergy 1981;46:268-72.
20. Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ. Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis. Annals of Allergy Asthma and Immunology 2000;85:111-4.
21. Gupta SK. Reversion and antihistamines. Journal of Association of Physicians of India 1996;44(1):72-3.
22. Allen ED, Whitaker ER, Ryu G. [Six-week trial of nebulised flunisolide nasal spray: efficacy in young children with moderately severe asthma]. Pediatric Pulmonology 1997;24:397-405.
23. Bousquet J, Van Cauwenberge P, Khaltaev N. [Allergic Rhinitis and its Impact on Asthma (ARIA)]. Journal of Allergy and Clinical Immunology 2001;108(5 Suppl):S147-334.
24. British Thoracic Society. [The british guidelines on asthma management 1995, review and position statement]. Thorax 1997;52(S51).
25. Chanez P, Vignola AM, Vic P, Guddo F, Buonsignore G, Godard P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. American Journal of Respiratory and Critical Care Medicine 1999;159:588-95.
26. Fireman P. [Rhinitis and asthma connection: management of coexisting upper airway allergic disease and asthma]. Allergy and Asthma Proceedings 2000;21(1):45-54.
27. Gawchik SM, Saccar CL. [A risk-benefit assessment of intranasal triamcinolone acetonide in allergic rhinitis]. Drug Safety 2000;23(4):309-22.
28. Greisner WA, Settipane RJ, Settipane GA. [Allergy and Asthma Proceedings]. 2000 21;6(371-6).
29. Jadad AR, Moore RA, Carrol D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
30. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, et al. [Systematic reviews and meta-analysis on treatment of asthma: critical evaluation]. British Medical Journal 2000;320:537-40.
31. Kapsali T, Horowitz E, Diemer F, Togias A. [Rhinitis is ubiquitous in allergic asthmatics]. Journal of Allergy and Clinical Immunology 1997;99(S138).
32. Leynaert B, Neukirch F, Demoly P, Bousquet J. [Epidemiologic evidence for asthma and rhinitis comorbidity]. Journal of Allergy and Clinical Immunology 2000;106(5):S201-5.
33. Lundback B. [Epidemiology of rhinitis and asthma]. Clinical and Experimental Allergy 1998;28(2):S3-10.
34. Mygind N, Dahl R, Nielsen LP. [Effect of nasal inflammation and of intranasal anti-inflammatory treatment on bronchial asthma]. Respiratory Medicine 1998;92(547-9).
35. NAC. [Asthma Management Plan]. Asthma Management Handbook 1998. [http://www.NationalAsthma.org.au]
36. National Heart, Lung and Blood Institute. [National asthma education and prevention program expert panel report 2. Guidelines for the diagnosis and management of asthma]. NIH Publication 1997, (97-4051).
37. Passalacqua G, Ciprandi G, Canonica GW. The nose-lung interaction in allergic rhinitis and asthma: united airways disease. Current Opinion in Allergy and Clinical Immunology 2001;1:7-13.
38. Pauwels R. [Influence of treatment on the nose and/or the lungs]. Clinical Experimental Allergy 1998;28:S37-40.
39. Pedersen W, Hjuler I, Bisgaard H, Mygind N. [Nasal inhalation of budesonide from a spacer in children with perennial rhinitis and asthma]. Allergy 1998;53(4):383-7.
40. Scadding GK. [Other anti-inflammatory uses of intranasal corticosteroids in upper respiratory inflammatory diseases]. Allergy 2000;55(62):S19-23.
41. Simons FE. [Allergic rhinobronchitis: The asthma-allergic rhinitis link]. Journal of Allergy and Clinical Immunology 1999;104:534-40.
42. Spector SL. [Overview of comorbid associations of allergic rhinitis]. Journal of Allergy and Clinical Immunology 1997;99:S773-80.
43. Thio BJ, Slingerland GL, Fredriks AM, Nagelkerke AF, Scheeren RA, Neijens HJ, et al. [Influence of intranasal steroids during the grass pollen season on bronchial responsiveness in children with asthma and hay fever]. Thorax 2000;55:826-32.
44. Togias A. Rhinitis and asthma: evidence for respiratory system integration. Journal of Allergy and Clinical Immunology 2003;111:1171-83.
45. Weiss KB, Sullivan SD. [The health economics of asthma and rhinitis.I. Assessing the economic impact]. Journal of Allergy and Clinical Immunology 2001;107:3-8.
46. WHO and National Heart, Lung and Blood Institute. [Global strategy for asthma management and prevention workshop report. Global Initiative for Asthma (GINA)]. NIH Publication No 96-3659A 1995.
47. Wood RA, Eggleston PA. [The effects of intranasal steroids on nasal and pulmonary responses to cat exposure]. American Journal or Respiratory and Critical Care Medicine 1995;151:315-20.